188 related articles for article (PubMed ID: 18446138)
1. Discussion of the 2007 British Society for Rheumatology guidelines for management of ANCA-associated vasculitis.
Villa-Forte A; Hoffman GS
Nat Clin Pract Rheumatol; 2008 Jun; 4(6):284-5. PubMed ID: 18446138
[No Abstract] [Full Text] [Related]
2. When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
Flossmann O; de Groot K
Nat Clin Pract Nephrol; 2007 May; 3(5):236-7. PubMed ID: 17457358
[No Abstract] [Full Text] [Related]
3. Towards diagnostic criteria for the ANCA-associated vasculitides.
Luqmani RA
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S57. PubMed ID: 17428369
[No Abstract] [Full Text] [Related]
4. Targeting B lymphocytes as therapy for ANCA-associated vasculitis.
Golbin JM; Specks U
Rheum Dis Clin North Am; 2007 Nov; 33(4):741-54, v. PubMed ID: 18037114
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibody vasculitis associated with mycobacterium avium intracellulare infection.
Chaiamnuay S; Heck LW
J Rheumatol; 2005 Aug; 32(8):1610-2. PubMed ID: 16078343
[TBL] [Abstract][Full Text] [Related]
6. Immunopathology and new therapeutic considerations in ANCA-associated vasculitides.
Gross WL
Autoimmun Rev; 2004 Jun; 3 Suppl 1():S47-8. PubMed ID: 15309793
[No Abstract] [Full Text] [Related]
7. Evidence-based management of ANCA vasculitis.
Carruthers D; Sherlock J
Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):367-78. PubMed ID: 19508944
[TBL] [Abstract][Full Text] [Related]
8. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
Lapraik C; Watts R; Bacon P; Carruthers D; Chakravarty K; D'Cruz D; Guillevin L; Harper L; Jayne D; Luqmani R; Mooney J; Scott D;
Rheumatology (Oxford); 2007 Oct; 46(10):1615-6. PubMed ID: 17804455
[No Abstract] [Full Text] [Related]
9. [Antineutrophil cytoplasmic antibodies (ANCA). Their contribution to the pathogenesis of vasculitis].
Mirapeix E
Med Clin (Barc); 1998 Jun; 110(20):778-80. PubMed ID: 9666419
[No Abstract] [Full Text] [Related]
10. [Diagnosis und therapy of ANCA-associated vasculitis].
Aries PM; Hellmich B; Gross WL
Dtsch Med Wochenschr; 2006 Mar; 131(9):443-6. PubMed ID: 16493569
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis.
Almroth G; Berlin G; Andersson B; Hahn-Zoric M
Scand J Urol Nephrol; 2009; 43(2):160-70. PubMed ID: 18979374
[TBL] [Abstract][Full Text] [Related]
12. [ANCA-associated vasculitides. Classifying the disease and its activity according to EULAR/EUVAS recommendations].
Holle JU; Lamprecht P
Z Rheumatol; 2009 Feb; 68(1):75-80. PubMed ID: 19093126
[No Abstract] [Full Text] [Related]
13. Systemic small vessel vasculitis: pathophysiological aspects of antineutrophil cytoplasm antibodies (ANCA). A review on recent findings.
Wiik A
Autoimmun Rev; 2004 Jun; 3 Suppl 1():S51-3. PubMed ID: 15309795
[No Abstract] [Full Text] [Related]
14. ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapy.
Holle JU; Gross WL
J Autoimmun; 2009; 32(3-4):163-71. PubMed ID: 19345067
[TBL] [Abstract][Full Text] [Related]
15. [XIII International Vasculitis and ANCA Workshop].
Maiorca P
G Ital Nefrol; 2007; 24(6):497. PubMed ID: 18278753
[No Abstract] [Full Text] [Related]
16. [Goodpasture syndrome associated with p-ANCA microscopic vasculitis: a rare entity to recognize].
Pralong G; Fournier C; Dayer E; Meier P
Rev Med Suisse; 2009 Jun; 5(207):1330-4. PubMed ID: 19626934
[TBL] [Abstract][Full Text] [Related]
17. Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Flossmann O; Jones RB; Jayne DR; Luqmani RA
Ann Rheum Dis; 2006 Jul; 65(7):841-4. PubMed ID: 16769779
[TBL] [Abstract][Full Text] [Related]
18. [Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)].
Kötter I
Z Rheumatol; 2009 Sep; 68(7):575-7. PubMed ID: 19652987
[No Abstract] [Full Text] [Related]
19. Bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies (ANCA) and associated diseases: clinical relevance of an emerging ANCA target antigen.
Emmi L; Chatzipetrou A
Ann Ital Med Int; 2005; 20(4):205-8. PubMed ID: 16610250
[No Abstract] [Full Text] [Related]
20. Appropriateness of antineutrophil cytoplasmic antibody testing in a tertiary hospital.
Robinson PC; Steele RH
J Clin Pathol; 2009 Aug; 62(8):743-5. PubMed ID: 19638546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
